IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.340
-0.040 (-2.90%)
At close: Oct 9, 2026, 4:00 PM EDT
1.380
+0.040 (2.99%)
After-hours: Oct 9, 2026, 7:42 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $13.21 million as of October 9, 2026. It is the 40,023rd most valuable company in the world and the 5,490th biggest in the United States. Its market cap has increased by 20.74% in one year.
Market Cap
13.21M
Enterprise Value
-2.57M
1-Year Change
20.74%
Global Rank
Country Rank
#5,490 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $13.21M, a decrease of -92.96%. That is a compound annual growth rate of -39.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 13.21M | -42.17% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 14.67M |
| Actuate Therapeutics | 14.65M |
| Cerenome | 14.65M |
| Lipocine | 14.18M |
| AEON Biopharma | 13.77M |
| Tvardi Therapeutics | 13.74M |
| Karyopharm Therapeutics | 13.72M |
| Citius Pharmaceuticals | 13.71M |